Skip to main content
Home
Issues
2024
November 2024 Vol 17, Payers' Guide to FDA Updates
2023
December 2023 Vol 16, Payers' Guide to FDA Updates
September 2023 Vol 16, Payers' Guide to FDA Updates
June 2023 - Vol 16 No 1
Issue Archive
Topics
Conference Correspondent
ESMO 2024 - Small Cell Lung Cancer
EHA 2024 – Wrap-Up: Myelodysplastic Syndrome
ASCO 2024 – Wrap-Up: Myelodysplastic Syndrome
Multimedia
Videos
Interview with the Innovators
Editorial Board
About
About AHDB
Contact Us
Permissions
Editorial Policies
Editorial Process
Advertising Policy
Subscribe
Home
Issues
2024
November 2024 Vol 17, Payers' Guide to FDA Updates
2023
December 2023 Vol 16, Payers' Guide to FDA Updates
September 2023 Vol 16, Payers' Guide to FDA Updates
June 2023 - Vol 16 No 1
Issue Archive
Topics
Conference Correspondent
ESMO 2024 - Small Cell Lung Cancer
EHA 2024 – Wrap-Up: Myelodysplastic Syndrome
ASCO 2024 – Wrap-Up: Myelodysplastic Syndrome
Multimedia
Videos
Interview with the Innovators
Editorial Board
About
About AHDB
Contact Us
Permissions
Editorial Policies
Editorial Process
Advertising Policy
Articles
Payer Coverage in Polycythemia Vera
Read More
Optimal Value-Based Therapy
Read More
Costs of Treatment in Polycythemia Vera
Read More
Payer Tools for Patient Care
Read More
Managing Oncology Costs in Polycythemia Vera
Read More
Affordable High Quality Care for Patients
Read More
Perspectives
Personalized Medicine: Are We There Yet?
Read More
Perspectives
Rewarding Innovation in Drug Development
Read More
Original Research
Evaluation of Dabigatran for Appropriateness of Use and Bleeding Events in a Community Hospital Setting
Stakeholder Perspective
Accurate Prescribing Key to Safe Use of Anticoagulants in Patients with Nonvalvular Atrial Fibrillation
Read More
Original Research
Patient Preferences and Treatment Adherence Among Women Diagnosed with Metastatic Breast Cancer
Stakeholder Perspective
Predicting Behavior: It’s a Matter of Preference
Read More
140
141
142
143
144
145
146
Page 143 of 244
Results 1421 - 1430 of 2434